Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapy targeting colon cancer stem cells.
Iovino F, Meraviglia S, Spina M, Orlando V, Saladino V, Dieli F, Stassi G, Todaro M. Iovino F, et al. Among authors: orlando v. Immunotherapy. 2011 Jan;3(1):97-106. doi: 10.2217/imt.10.87. Immunotherapy. 2011. PMID: 21174560 Review.
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.
Todaro M, D'Asaro M, Caccamo N, Iovino F, Francipane MG, Meraviglia S, Orlando V, La Mendola C, Gulotta G, Salerno A, Dieli F, Stassi G. Todaro M, et al. Among authors: orlando v. J Immunol. 2009 Jun 1;182(11):7287-96. doi: 10.4049/jimmunol.0804288. J Immunol. 2009. PMID: 19454726
V gamma 9V delta 2 T lymphocytes efficiently recognize and kill zoledronate-sensitized, imatinib-sensitive, and imatinib-resistant chronic myelogenous leukemia cells.
D'Asaro M, La Mendola C, Di Liberto D, Orlando V, Todaro M, Spina M, Guggino G, Meraviglia S, Caccamo N, Messina A, Salerno A, Di Raimondo F, Vigneri P, Stassi G, Fourniè JJ, Dieli F. D'Asaro M, et al. Among authors: orlando v. J Immunol. 2010 Mar 15;184(6):3260-8. doi: 10.4049/jimmunol.0903454. Epub 2010 Feb 12. J Immunol. 2010. PMID: 20154204
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.
Meraviglia S, Eberl M, Vermijlen D, Todaro M, Buccheri S, Cicero G, La Mendola C, Guggino G, D'Asaro M, Orlando V, Scarpa F, Roberts A, Caccamo N, Stassi G, Dieli F, Hayday AC. Meraviglia S, et al. Among authors: orlando v. Clin Exp Immunol. 2010 Aug;161(2):290-7. doi: 10.1111/j.1365-2249.2010.04167.x. Epub 2010 May 10. Clin Exp Immunol. 2010. PMID: 20491785 Free PMC article. Clinical Trial.
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.
Cordova A, Toia F, La Mendola C, Orlando V, Meraviglia S, Rinaldi G, Todaro M, Cicero G, Zichichi L, Donni PL, Caccamo N, Stassi G, Dieli F, Moschella F. Cordova A, et al. Among authors: orlando v. PLoS One. 2012;7(11):e49878. doi: 10.1371/journal.pone.0049878. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189169 Free PMC article.
247 results